Equity Overview
Price & Market Data
Price: $5.00
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $9,260,159
Volume: 0
Performance Metrics
1 Week: 18.76%
1 Month: -17.36%
3 Months: -29.18%
6 Months: -31.51%
1 Year: -60.00%
YTD: -33.07%
Details
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.